Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

PURPOSE: Pancreatic neuroendocrine tumors (pNETs) are uncommon malignancies noted for their propensity to metastasize and comparatively favorable prognosis. Although both the treatment options and clinical outcomes have improved in the last decades, most patients will die of metastatic disease. New...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cancer Res
Autori principali: Scott, Aaron T., Weitz, Michelle, Breheny, Patrick J., Ear, Po Hien, Darbro, Benjamin W., Brown, Bart J., Braun, Terry A., Li, Guiying, Umesalma, Shaikamjad, Kaemmer, Courtney, Maharjan, Chandra Kumar, Quelle, Dawn E., Bellizzi, Andrew M., Chandrasekharan, Chandrikha, Dillon, Joseph S., O’Dorisio, Thomas M., Howe, James R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7165057/
https://ncbi.nlm.nih.gov/pubmed/31937620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-2884
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi